Aberrant expression of miR-203 and its clinical significance in gastric and colorectal cancers. - Wikidata - awgldk - TriplyDB

Aberrant expression of miR-203 and its clinical significance in gastric and colorectal cancers.

Aberrant expression of miR-203 and its clinical significance in gastric and colorectal cancers.

http://www.wikidata.org/entity/Q39633731

about

Identification of microRNAs as potential prognostic markers in ependymoma Mutational analysis of merkel cell carcinoma MiR-29a inhibits cell proliferation and induces cell cycle arrest through the downregulation of p42.3 in human gastric cancer MicroRNA-1258: An invasion and metastasis regulator that targets heparanase in gastric cancer Clinical significance of promoter region hypermethylation of microRNA-148a in gastrointestinal cancers.MicroRNA analysis of microdissected normal squamous esophageal epithelium and tumor cells Inverse association between miR-194 expression and tumor invasion in gastric cancer.microRNA-192, -194 and -215 are frequently downregulated in colorectal cancer Serum microRNA panel as biomarkers for early diagnosis of colorectal adenocarcinoma Down-regulation of miR-129-5p inhibits growth and induces apoptosis in laryngeal squamous cell carcinoma by targeting APC.Epigenetic Silencing of miR-203 Upregulates SNAI2 and Contributes to the Invasiveness of Malignant Breast Cancer Cells.MicroRNA-335 acts as a metastasis suppressor in gastric cancer by targeting Bcl-w and specificity protein 1 The role of microRNAs in Helicobacter pylori pathogenesis and gastric carcinogenesis.By downregulating TIAM1 expression, microRNA-329 suppresses gastric cancer invasion and growth Comparative effects of diet and carcinogen on microRNA expression in the stem cell niche of the mouse colonic crypt The Diagnostic and Prognostic Role of microRNA in Colorectal Cancer - a Comprehensive review miR-139-5p Inhibits the Epithelial-Mesenchymal Transition and Enhances the Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating BCL2 Examining plasma microRNA markers for colorectal cancer at different stages.MiRNA-203 suppresses cell proliferation, migration and invasion in colorectal cancer via targeting of EIF5A2.miR-203 is involved in the laryngeal carcinoma pathogenesis via targeting VEGFA and Cox-2.miRNA: The nemesis of gastric cancer (Review).MicroRNA expression patterns related to merkel cell polyomavirus infection in human merkel cell carcinoma.miRNA-129-5p suppresses cell proliferation and invasion in lung cancer by targeting microspherule protein 1, E-cadherin and vimentin.MicroRNA-203 predicts human survival after resection of colorectal liver metastasis.MicroRNA replacement therapy for cancer.Epigenetic mechanisms in gastric cancer.Roles of microRNAs during prostatic tumorigenesis and tumor progression.Role of microRNAs in the immune system, inflammation and cancer.MicroRNAs targeting EGFR signalling pathway in colorectal cancer.Analysis of gene expression EGFR and KRAS, microRNA-21 and microRNA-203 in patients with colon and rectal cancer and correlation with clinical outcome and prognostic factors.Overexpression of miR-203 sensitizes paclitaxel (Taxol)-resistant colorectal cancer cells through targeting the salt-inducible kinase 2 (SIK2).MiR-203 inhibits tumor invasion and metastasis in gastric cancer by ATM.Berberine modulates cisplatin sensitivity of human gastric cancer cells by upregulation of miR-203.MiR-129-5p suppresses gastric cancer cell invasion and proliferation by inhibiting COL1A1.Interplay Between Transcription Factors and MicroRNAs Regulating Epithelial-Mesenchymal Transitions in Colorectal Cancer.miR-203 is a direct transcriptional target of E2F1 and causes G1 arrest in esophageal cancer cells.Potential roles of microRNAs and ROS in colorectal cancer: diagnostic biomarkers and therapeutic targets.Protamine sulfate-nanodiamond hybrid nanoparticles as a vector for MiR-203 restoration in esophageal carcinoma cells.miR-144 downregulation increases bladder cancer cell proliferation by targeting EZH2 and regulating Wnt signaling.MicroRNA-203 leads to G1 phase cell cycle arrest in laryngeal carcinoma cells by directly targeting survivin.

P2860

Q21135016-88D9C1FA-7241-40E5-AFE1-D4A23DF3C9D2 Q27021034-22FEAA0F-72CB-46BD-9E9E-3C626A8B39D7 Q31037470-AF3F19F2-96B3-4301-9977-CF63E9024875 Q33684807-738B7E92-9208-458E-89BE-F7E53D3A824B Q33710125-6AEFBFEC-A4F1-41FD-921E-9925D987E318 Q33973612-66A32027-2E5F-4C4D-AEB8-E95F42820698 Q34208375-149AAF9A-DA99-4F53-8DA1-B7855214E810 Q34299181-C2892393-F37E-4E84-B277-6C2787B75748 Q34499638-A2BEFC71-BA84-4621-80EC-7DAA446CDA26 Q35032477-CF4C0A5F-B68A-4FB8-A3F5-5454C2CF5D80 Q35755187-10EDA92C-068B-45F3-BA63-29828B3D3D04 Q35853031-C077041D-02A8-436B-AC16-EFBEC5A440C9 Q36158807-19D9C448-960E-4EA1-8236-78B70D0E8100 Q36232099-DCFEEA33-CEFC-424E-A41F-77EF3B733858 Q36359569-DF960310-82F6-40AE-9994-E2FBA179E5EF Q36646576-0C842B19-4D18-4A43-90A3-00A9810B9DA5 Q36950630-306E4DE6-41F2-4D8E-8BDE-81BAB7936349 Q36998271-63ED3BAD-5922-47A8-8FC1-36B3D33D2BB1 Q37062650-1BD973F9-8E9F-44F9-A081-4BC26C481FD0 Q37142987-788CAF34-58CB-4D50-ADA2-6EC883FEF1DC Q37211784-C15040E0-842A-4C4A-A2DC-F50111A6F6D5 Q37501838-3F7ED758-EFF9-4077-B718-160AF9BB9CA2 Q37582395-16386BA2-D452-46BB-96EB-84D52E53338F Q37745844-B6EC7820-6BA1-4A95-B7AE-AC3F48CC575F Q37924177-D7CA3684-AD98-45A3-A245-FC0A1DB682BD Q38018086-B7C5027C-8DFB-46C6-8D52-653C57E5596E Q38086009-2A5E9F56-001A-4ED6-A8D7-ACBC4B73202F Q38110271-B6A279D9-BFF2-44E6-9506-CE5A25498D64 Q38118612-FBEFDA64-BDF6-413C-B897-866EA51143E1 Q38731234-C1042505-86EA-43C8-BC2B-2DC1B6253395 Q38737059-C9C4C089-01BE-4152-99D2-576B6D249C52 Q38751011-DD83BABD-773A-42CA-9B93-E34E5833CA19 Q38773397-4CA89CC9-B80B-453C-B4B5-E7AC2D793614 Q38797965-CEFBAE51-6425-4DC6-87DE-A5D45B04E94C Q38940594-A590DEE2-2E15-4488-9853-73265F9EB9CC Q38957100-DFA39853-7E31-4A41-BDDB-0370F1870E9E Q39070721-9FC39456-9129-41D4-BBAC-DF050B440746 Q39072293-3A617960-12C2-41FD-9DDF-4933E6B980B0 Q39132530-C3134950-4F48-42FA-9D2A-28F4C65E0284 Q39401468-8D66D180-BC5D-4868-8C86-1700A836305A

P2860

Aberrant expression of miR-203 and its clinical significance in gastric and colorectal cancers.

http://www.wikidata.org/entity/Q39633731

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Aberrant expression of miR-203 ...... astric and colorectal cancers.

@en

Aberrant expression of miR-203 ...... astric and colorectal cancers.

@nl

type

label

Aberrant expression of miR-203 ...... astric and colorectal cancers.

@en

Aberrant expression of miR-203 ...... astric and colorectal cancers.

@nl

prefLabel

Aberrant expression of miR-203 ...... astric and colorectal cancers.

@en

Aberrant expression of miR-203 ...... astric and colorectal cancers.

@nl

P1433

Q39633731-EFEDD9B7-4BD0-4F1F-83B1-C92096CF015B

P1476

Q39633731-EB1ABDEA-3F51-4071-ADF6-0CE9E08D75B5

P2093

Q39633731-124E6598-F231-4B11-92BE-AC003624A0F9

Q39633731-1D3C0519-438F-40D6-A837-449513C29356

Q39633731-45F976F6-5F46-4D3F-8B97-3AD94A10997D

Q39633731-B1FD5FB8-7579-4100-9CD6-B0DB50184A3A

Q39633731-C998313D-985B-4C2B-AEF0-576A1A21AE6B

Q39633731-CF663ED7-D7D2-43C0-A636-09025416DB5D

Q39633731-EF3DA82F-30FA-4EE2-82ED-09D99A35ADB6

P2860

Q39633731-08148F0B-A052-48BF-9C39-9F615CE30AF7

Q39633731-1598F8E8-3F34-4D05-991D-824A509316ED

Q39633731-1BFD3CAC-EAE3-4F34-9C59-18948B8B91D8

Q39633731-2107E632-36D8-4D30-AD12-97B14F4B9579

Q39633731-24236289-8D49-4430-BA7C-5C3740856477

Q39633731-28338C76-CD85-455A-A32C-A3F9F33F9C4D

Q39633731-28F5893B-7740-405F-8530-F57AC9418128

Q39633731-29F85383-3654-4288-8F3A-5798E5EBEEC1

Q39633731-3A162E86-7F1E-4CA2-A33E-7459A0B809B7

Q39633731-3E7E61FE-2B35-4697-B27F-27955DCE72B3

P2888

Q39633731-576CB7AE-B430-42FC-93AE-4717E3721B3F

P304

Q39633731-6E1625FF-3B5E-4C45-A90E-0B7367B7078A

P31

Q39633731-3D8E639D-2523-4926-9E8E-71685D739CCF

P356

Q39633731-42EABBD2-3D96-4C59-9D8B-B8523052FA7E

P433

Q39633731-1E2D19BF-2019-443D-AB76-01E27486DB59

P478

Q39633731-CD58CD40-5370-4CC5-B01B-43771A388A2D

P50

Q39633731-60ADCCF6-5512-4CC1-BF90-C390015DB90F

P577

Q39633731-C408BDFD-2E9F-4A3F-9427-81E68628BCE6

P698

Q39633731-DDF0E90B-4888-4141-A241-88234A8CD18F

P356

S11605-010-1367-8

P1433

Journal of Gastrointestinal Surgery

P1476

Aberrant expression of miR-203 ...... gastric and colorectal cancers

@en

P2093

Chengzhong Xing

http://www.w3.org/2001/XMLSchema#string

Huimian Xu

http://www.w3.org/2001/XMLSchema#string

Yeunpo Chiang

http://www.w3.org/2001/XMLSchema#string

Yongxi Song

http://www.w3.org/2001/XMLSchema#string

Yue Chen

http://www.w3.org/2001/XMLSchema#string

Zhenyu Yue

http://www.w3.org/2001/XMLSchema#string

Zhuangkai Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

A microRNA expression signature of human solid tumors defines cancer gene targets

MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Unique microRNA molecular profiles in lung cancer diagnosis and prognosis

MicroRNA gene expression deregulation in human breast cancer

Oncomirs - microRNAs with a role in cancer

MicroRNA signatures in human cancers

Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs

MicroRNAs: genomics, biogenesis, mechanism, and function

P2888

s11605-010-1367-8

P304

63-70

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11605-010-1367-8

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-11-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21063914

http://www.w3.org/2001/XMLSchema#string